Several previous studies revealed that BCL6B interacts with the Notch, STAT, p53 and PI3K/AKT signalling pathways [15, 16, 21, 22], which may be involved in the regulation of the inflammatory response in cancer cells. Here, BCL6B is linked to cancer.